ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

AUPH Aurinia Pharmaceuticals Inc

4,9001
0,0301 (0,62%)
27 Abr 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Aurinia Pharmaceuticals Inc AUPH NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,0301 0,62% 4,9001 01:00:07
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
4,89 4,86 5,01 4,91 4,87
mais cotações »

Notícias Recentes

Data Hora Fonte Título
16/04/202411:48BWUPDATE: New Aurinia Presentation Details at the 2024 Bloom..
15/04/202407:00BWAurinia Pharmaceuticals to Release First Quarter Financial..
09/04/202407:00BWAurinia Will Attend 2024 Bloom Burton & Co. Healthcare..
29/02/202410:30BWAurinia Receives Exemptive Relief from Canadian Securities..
27/02/202410:30BWAurinia to Participate in Upcoming Investor Healthcare..
15/02/202408:00BWAurinia Discloses 2023 Year-End Financial and Operational..
05/02/202410:30BWAurinia Pharmaceuticals to Release 2023 Fourth Quarter and..
05/01/202408:00BWAurinia Provides Preliminary Unaudited Fourth Quarter and..
20/12/202308:00BWAurinia Submits IND Application to US Food & Drug..
13/11/202308:00BWAurinia Pharmaceuticals Announces Collaboration Partner..
07/11/202312:30BWAurinia Presents Breadth of Data from AURORA Clinical..
02/11/202319:00BWAurinia Presents Breadth of Data at ASN 2023 Demonstrating..
02/11/202307:00BWAurinia Pharmaceuticals Reports Third Quarter and Nine..
26/10/202316:00BWAurinia Response in Support of 2023 Updated EULAR..
19/10/202311:31BWCORRECTING and REPLACING Aurinia Pharmaceuticals to Release..
19/10/202307:00BWAurinia Pharmaceuticals to Release Third Quarter Financial..
13/10/202313:00BWAurinia Pharmaceuticals Announces Presentations at American..
21/09/202307:00BWAurinia Board of Directors Appoints Dr. Robert T. Foster as..
21/08/202307:00BWAurinia Appoints Two New Board Directors with Deep..
03/08/202307:00BWAurinia Pharmaceuticals Reports Second Quarter and Six..
20/07/202307:00BWAurinia Pharmaceuticals to Release Second Quarter Financial..
19/07/202313:05BWLong Term Phase 3 Data Published in Arthritis & Rheumatology..
29/06/202317:05BWAurinia Board of Directors Announces Exploration of..
20/06/202310:00BWAurinia Showcases Three Oral Presentations for LUPKYNIS®..
01/06/202310:00BWLUPKYNIS® (voclosporin) Achieved Significantly Higher Renal..
26/05/202318:16BWAurinia Files Form S-8 to Register Shares Underlying..
17/05/202313:14BWAurinia Announces 2023 Annual General Meeting Results
09/05/202307:00BWAurinia Pharmaceuticals Announces Kidney Biopsies Sub-study..
04/05/202307:00BWAurinia Pharmaceuticals Reports First Quarter 2023 Financial..
03/05/202308:51BWAurinia Pharmaceuticals Announces NICE Recommendation of..
02/05/202317:36BWISS Joins Glass Lewis in Recommending Aurinia Shareholders..
02/05/202313:00BWAurinia Pharmaceuticals Announces Swissmedic Approval of..

Seu Histórico Recente

Delayed Upgrade Clock